Pharma and Biotech
| Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
|---|---|---|---|---|---|
| 30-Jun-25 | Interim | n/a | (1.62) | (0.06)p | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.52 | (0.45) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.22 | (0.95) | (1.36)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.54 | (2.70) | (2.61)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 0.59 | (3.12) | (3.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (1.45) | (0.12)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 0.32p |
| Change Today | 0.011p |
| % Change | 3.58 % |
| 52 Week High | 0.39 |
| 52 Week Low | 0.12 |
| Volume | 65,917,557 |
| Shares Issued | 6,806m |
| Market Cap | £21.86m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:07 | 1,000,000 @ 0.32p |
| 11:00 | 200,000 @ 0.32p |
| 11:00 | 200,000 @ 0.32p |
| 10:03 | 3,816,522 @ 0.31p |
| 10:03 | 1,587,302 @ 0.32p |
| CEO | Anthony Tennyson |
| Chair | Dennis Purcell |
You are here: research